UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053056
Receipt number R000060535
Scientific Title Observational Study on the Relationship between Physical Activity, Physical Function, Higher Level Competence, and Social Networks after Discharge in Patients with Heart Failure
Date of disclosure of the study information 2023/12/15
Last modified on 2023/12/11 14:18:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational Study on the Relationship between Physical Activity, Physical Function, Higher Level Competence, and Social Networks after Discharge in Patients with Heart Failure

Acronym

Observational Study on the Relationship between Physical Activity, Physical Function, Higher Level Competence, and Social Networks after Discharge in Patients with Heart Failure

Scientific Title

Observational Study on the Relationship between Physical Activity, Physical Function, Higher Level Competence, and Social Networks after Discharge in Patients with Heart Failure

Scientific Title:Acronym

Observational Study on the Relationship between Physical Activity, Physical Function, Higher Level Competence, and Social Networks after Discharge in Patients with Heart Failure

Region

Japan


Condition

Condition

heart failure

Classification by specialty

Cardiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to illustrate the association between physical function, higher-level activity abilities, and social networks with the volume of physical activity throughout one-month post-discharge in patients admitted with decompensated heart failure, thereby highlighting the significance of higher-level competence and social network in the management of heart failure.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The physical activity measured using an accelerometer for one month after discharge.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Heart failure patients aged 65 years or older discharged from a hospital enrolled in the study site who have given consent for this study

Key exclusion criteria

Subjects with a decline in psychocognitive function that makes it difficult to understand the instructions for evaluation and fitting of measurement devices. Subjects with a cerebrovascular or orthopedic disease that makes it difficult to stand or walk. Subjects with a decline in ability to perform activities of daily living with a Berthel Index: BI score less than 85. Subjects who received treatment related to ischemic heart disease during hospitalization. Others whom the principal investigator judged to be inappropriate as subjects.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Tetsuroh
Middle name
Last name Tamaru

Organization

Shinshu University Graduate School

Division name

Graduate School of Medicine, Science and Technology, Department of Medical Sciences, Health Science Division

Zip code

3908621

Address

3-1 Asahi, Matsumoto City, Nagano Prefecture

TEL

0263-37-3376

Email

20ms114h@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Tetsuroh
Middle name
Last name Tamaru

Organization

Shinshu University Graduate School

Division name

Graduate School of Medicine, Science and Technology, Department of Medical Sciences, Health Science

Zip code

3908621

Address

3-1 Asahi, Matsumoto City, Nagano Prefecture

TEL

0263-37-3376

Homepage URL


Email

20ms114h@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University Graduate School

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nagano Central Hospital, Nagano Municipal Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu university

Address

3-1 Asahi, Matsumoto City, Nagano Prefecture

Tel

0263-37-3376

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 03 Month 01 Day

Date of IRB

2022 Year 10 Month 11 Day

Anticipated trial start date

2023 Year 03 Month 01 Day

Last follow-up date

2026 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patient background includes age, gender, height, weight, and marital status. Vital signs include systolic blood pressure, diastolic blood pressure, and heart rate at the time of discharge from the hospital, blood chemistry tests including sodium, hemoglobin, creatinine, basal glomerular filtration rate, urea nitrogen, cerebral sodium peptide, and left ventricular ejection fraction on echocardiography. Blood biochemical tests include sodium, hemoglobin, creatinine, basal glomerular filtration rate, urea nitrogen, cerebral sodium peptide, left ventricular ejection fraction on echocardiography, and the use of ACE inhibitors, ARBs, beta blockers, MRAs, SGLT2 inhibitors, and ARNI as drug information. NYHA classification and heart failure stage classification will be evaluated as heart failure severity. Physical function will be assessed by 6-minute walk test, SPPB, and grip strength. Physical activity will be measured using active style pro (Omron Healthcare). The following data will be collected: 1) total number of steps per day (steps), 2) total activity (Mets*h), 3) daily activity (Mets*h), 4) walking activity (Mets*h), and 5) percentage of daily activity in the total activity. The Luben social network scale is used for social network. For higher activity capacity, we will use the Institute of Elderly Medicine's Activity Capacity Index and the JST version of the Activity Capacity Index.


Management information

Registered date

2023 Year 12 Month 11 Day

Last modified on

2023 Year 12 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060535


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name